Your browser is no longer supported. Please, upgrade your browser.
Settings
ZSAN Zosano Pharma Corporation daily Stock Chart
ZSAN [NASD]
Zosano Pharma Corporation
Index- P/E- EPS (ttm)-1.50 Insider Own0.80% Shs Outstand37.37M Perf Week-1.07%
Market Cap36.60M Forward P/E- EPS next Y-0.85 Insider Trans90.12% Shs Float34.71M Perf Month24.32%
Income-28.90M PEG- EPS next Q-0.18 Inst Own37.80% Short Float14.05% Perf Quarter-32.46%
Sales- P/S- EPS this Y13.00% Inst Trans-1.68% Short Ratio9.35 Perf Half Y-43.39%
Book/sh0.56 P/B1.75 EPS next Y0.00% ROA-89.90% Target Price4.00 Perf Year26.37%
Cash/sh0.76 P/C1.29 EPS next 5Y- ROE-172.80% 52W Range0.45 - 3.54 Perf YTD25.56%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-72.33% Beta-
Dividend %- Quick Ratio3.20 Sales past 5Y- Gross Margin- 52W Low116.68% ATR0.07
Employees39 Current Ratio3.20 Sales Q/Q- Oper. Margin- RSI (14)51.45 Volatility6.18% 9.10%
OptionableNo Debt/Eq0.44 EPS Q/Q68.30% Profit Margin- Rel Volume0.21 Prev Close0.96
ShortableYes LT Debt/Eq0.16 EarningsAug 10 AMC Payout- Avg Volume521.50K Price0.98
Recom2.00 SMA207.91% SMA50-4.62% SMA200-29.00% Volume110,300 Change2.45%
Mar-24-17Initiated Piper Jaffray Overweight $4
Aug-11-16Downgrade Ladenburg Thalmann Buy → Neutral
Nov-11-15Reiterated ROTH Capital Buy $11 → $7
Sep-29-15Reiterated ROTH Capital Buy $20 → $11
Feb-23-15Initiated ROTH Capital Buy $20
Sep-13-17 11:36AM  Zosano Presents Data from ZOTRIP Study at International Headache Society GlobeNewswire +10.31%
Aug-28-17 08:30AM  Zosano Pharma Announces US Patent Office Publication of Method of Rapidly Achieving Therapeutic Concentrations of Triptans for Treatment of Migraines GlobeNewswire
Aug-10-17 04:01PM  Zosano Pharma Reports Second Quarter 2017 Financial Results and Operational Update GlobeNewswire -5.05%
03:30PM  Investor Network: Zosano Pharma Corp. to Host Earnings Call ACCESSWIRE
Aug-02-17 08:30AM  Zosano Pharma to Host Conference Call on Second Quarter 2017 Financial Results and Provide Operational Update GlobeNewswire
Jul-31-17 09:30AM  Zosano Announces Publication of Positive Phase 1 Data of Zolmitriptan Delivery In Future Medicines Pain Management Journal GlobeNewswire
Jun-26-17 08:30AM  Zosano Pharma Announces Outcome of End of Phase 2 Meetings with FDA GlobeNewswire
Jun-14-17 04:01PM  Zosano Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Jun-12-17 08:30AM  Zosano Presents Additional Data from ZOTRIP Study at American Headache Society, Demonstrating Positive Results for Pain Freedom and Sustained Pain Freedom GlobeNewswire -9.33%
Jun-01-17 08:30AM  Zosano to Present Migraine Data at Three Industry-Leading Conferences GlobeNewswire
May-30-17 08:00AM  Today's Research Reports on Stocks to Watch: BioDelivery Sciences International and Zosano Pharma Accesswire
May-26-17 11:15PM  Zosano Pharma Corp (ZSAN) Interim CEO John Peter Walker Bought $100,254 of Shares GuruFocus.com +12.03%
May-09-17 04:00PM  Zosano Reports First Quarter 2017 Financial Results and Announces Management Changes GlobeNewswire
03:05PM  Investor Network: Zosano Pharma Corp. to Host Earnings Call Accesswire
May-08-17 05:30AM  Zosano Pharma to Host Conference Call on First Quarter 2017 Financial Results and Provide Operational Update GlobeNewswire
Apr-17-17 09:20AM  5 Drug Stocks That Could Be Big Winners this Earnings Season Zacks
Apr-04-17 09:47AM  Shkreli Gives Zosano a Giant Headache Investopedia -10.38%
09:47AM  Shkreli Gives Zosano a Giant Headache
Mar-31-17 12:00PM  Penny Stocks to Watch for April 2017 (ATRS, WRN) at Investopedia
Mar-22-17 04:01PM  Zosano Announces Closing of Public Offering of Common Stock and Exercise of Underwriters Over-Allotment Option GlobeNewswire
Mar-17-17 09:25AM  Zosano Announces Pricing of Public Offering of Common Stock GlobeNewswire -9.88%
08:55AM  ZOSANO PHARMA CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Mar-07-17 01:04PM  ZOSANO PHARMA CORP Financials -5.53%
Mar-02-17 05:21PM  Penny Stocks to Watch for March 2017 (MOBL) Investopedia
05:21PM  Penny Stocks to Watch for March 2017 (MOBL)
Mar-01-17 07:31AM  ZOSANO PHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
07:00AM  Zosano Pharma Reports Fourth Quarter and Fiscal 2016 Financial Results and Business Update GlobeNewswire
06:16AM  ZOSANO PHARMA CORP Files SEC form 10-K, Annual Report
Feb-16-17 09:30AM  Biotech Industry Shaping up to Have a Breakout Year in 2017: Today's Reports on Insys Therapeutics and Zosano Pharma Accesswire +7.72%
Feb-14-17 10:47AM  Zosano Pharma Corp (ZSAN) Is Playing With The Big Boys In The Migraine Space Insider Monkey +18.82%
10:47AM  Zosano Pharma Corp (ZSAN) Is Playing With The Big Boys In The Migraine Space at Insider Monkey
Feb-13-17 04:20PM  ZOSANO PHARMA CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits +41.67%
11:10AM  Can Zosano Pharma Turn Itself Around With This Late-Stage Migraine Trial Win? 24/7 Wall St.
11:10AM  Can Zosano Pharma Turn Itself Around With This Late-Stage Migraine Trial Win?
10:36AM  Fear of Missing Out Is Building TheStreet.com
10:36AM  Fear of Missing Out Is Building
09:56AM  Zosana Pharma's stock rockets after migraine patch produces positive trial results at MarketWatch
08:30AM  Zosano Pharma Announces 3.8mg Dose of M207, its Novel Transdermal Therapeutic, Meets Both Co-primary Endpoints in the ZOTRIP Pivotal Efficacy Trial in Migraine GlobeNewswire
Jan-25-17 04:37PM  ZOSANO PHARMA CORP Files SEC form 8-K, Other Events
Jan-23-17 05:18PM  Zosano Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Jan-05-17 08:30AM  Zosano Pharma Announces Last Subject Treated in its Migraine Pivotal Trial GlobeNewswire +11.47%
Nov-22-16 05:16PM  ZOSANO PHARMA CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -7.28%
05:00PM  Zosano Pharma Announces Sale of Non-Strategic Asset GlobeNewswire
Nov-09-16 04:35PM  ZOSANO PHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
04:20PM  Zosano Pharma Reports Third Quarter 2016 Financial Results GlobeNewswire
Nov-08-16 08:30AM  Zosano Pharma Announces Completion of Enrollment in Pivotal Efficacy Trial for M207 for Acute Migraine GlobeNewswire
Nov-03-16 04:15PM  ZOSANO PHARMA CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -16.52%
Oct-14-16 04:10PM  ZOSANO PHARMA CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
Oct-05-16 08:35PM  SHAREHOLDER NOTICE: Khang & Khang LLP Announces an Investigation of Zosano Pharma Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
Sep-09-16 05:00PM  Zosano Announces Inducement Grant for Georgia Erbez, Chief Business Officer GlobeNewswire
04:20PM  ZOSANO PHARMA CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Sep-08-16 08:30AM  Zosano Appoints Georgia Erbez as Chief Business Officer GlobeNewswire
Aug-31-16 02:28PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Shareholders of Zosano Pharma Corporation - ZSAN PR Newswire -13.41%
Aug-29-16 02:11PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Investigation of Zosano Pharma Corporation (ZSAN) Accesswire
Aug-26-16 09:54PM  IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces an Investigation of Zosano Pharma Corporation and Advises Investors With Losses in Excess of $10,000 Contact the Firm Business Wire -14.78%
05:31PM  ALERT: Rosen Law Firm Continues to Investigate Securities Claims Against Zosano Pharma Corporation Business Wire
Aug-22-16 11:15PM  Zosano Pharma Corp (ZSAN) President, CEO Konstantinos Alataris Bought $168,153 of Stocks -8.00%
Aug-16-16 09:01AM  ZOSANO PHARMA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements
08:40AM  Zosano Pharma Announces Pricing of Private Placement of Common Stock and Warrants GlobeNewswire
Aug-12-16 12:58PM  IMPORTANT ZOSANO ALERT: Lundin Law PC Announces an Ongoing Investigation of Zosano Pharma Corporation and Advises Investors with Losses In Excess of $10,000 to Contact the Firm Accesswire -8.11%
Aug-11-16 08:02AM  Ladenburg Thalmann Downgrades Zosano Pharma To Neutral On Financing Overhang, Market Uncertainty +6.47%
06:52AM  Zosano Pharma downgraded by Ladenburg Thalmann
Aug-10-16 04:22PM  ZOSANO PHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
04:15PM  Zosano Pharma Reports Second Quarter 2016 Financial Results GlobeNewswire
Aug-04-16 10:20AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of an Investigation of Zosano Pharma Corporation (ZSAN) Accesswire
Jul-25-16 08:30AM  First Subject Treated in Zosano Pharmas Pivotal Efficacy Trial for M207 Patch for Acute Migraine GlobeNewswire +25.00%
Jun-23-16 01:39PM  ZOSANO ALERT: Lundin Law PC Announces an Investigation of Zosano Pharma Corporation and Advises Investors with Losses to Contact the Firm Accesswire -10.01%
Jun-17-16 05:03PM  ZOSANO PHARMA CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
08:30AM  Zosano Pharma Enrolls First Subject in Pivotal Clinical Trial for ZP-Triptan Patch Program for Treatment of Migraine GlobeNewswire
Jun-15-16 06:50PM  ZOSANO INVESTIGATION ALERT: Khang & Khang LLP Announces An Ongoing Investigation of Claims against Zosano Pharma Corporation And Encourages Investors With Losses to Contact the Firm Accesswire
Jun-14-16 01:52PM  ONGOING INVESTIGATION: Lundin Law PC Announces Investigation of Zosano Pharma Corporation and Advises Investors with Losses to Contact the Firm Accesswire -9.04%
May-20-16 05:03PM  Edited Transcript of ZSAN earnings conference call or presentation 12-May-16 8:30pm GMT
May-17-16 12:20PM  INVESTIGATION ALERT: Khang & Khang LLP Announces An Ongoing Investigation of Claims against Zosano Pharma Corporation And Encourages Investors With Losses to Contact the Firm Accesswire -10.58%
11:58AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Zosano Pharma Corporation (ZSAN) PR Newswire
May-16-16 06:50PM  SHAREHOLDER ALERT: Lundin Law PC Announces Investigation Of Zosano Pharma Corporation And Advises Investors With Losses To Contact the Firm Accesswire -7.80%
May-13-16 04:06PM  ZOSANO PHARMA CORP Files SEC form 8-K, Change in Directors or Principal Officers
May-12-16 04:59PM  INVESTOR ALERT: Investigation of Zosano Pharma Corporation Announced by the Law Firm Goldman Scarlato & Penny, P.C.; Investors Encouraged to Contact the Firm Business Wire
04:14PM  ZOSANO PHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
04:05PM  Zosano Pharma Reports First Quarter 2016 Financial Results GlobeNewswire
07:07AM  Q1 2016 Zosano Pharma Corp Earnings Release - Time Not Supplied
May-09-16 11:51AM  ZOSANO PHARMA CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
08:30AM  Zosano Announces Appointment of John P. Walker as Chairman of the Board GlobeNewswire
May-02-16 04:05PM  Zosano Pharma to Report First Quarter 2016 Financial Results GlobeNewswire -7.13%
Apr-15-16 07:15PM  SHAREHOLDER ALERT: Lundin Law PC Announces Investigation of Zosano Pharma Corporation and Advises Investors with Losses to Contact the Firm Business Wire
11:13AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Shareholders of Zosano Pharma Corporation - ZSAN PR Newswire
11:04AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Violations of Federal Securities Laws by the Board of Zosano Pharma Corporation -- ZSAN Business Wire
Apr-14-16 11:11AM  EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Zosano Pharma Corporation Business Wire -11.54%
10:51AM  Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Zosano Pharma Corporation (ZSAN) PR Newswire
Apr-13-16 09:48PM  INVESTOR NOTICE: Goldberg Law PC Announces an Investigation of Claims Against Zosano Pharma Corporation and Advises Investors With Losses to Contact the Firm Business Wire
Apr-08-16 03:41PM  ZOSANO NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Zosano Pharma Corporation To Contact The Firm PR Newswire -7.23%
02:13PM  IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces An Investigation of Claims Against Zosano Pharma Corporation And Advises Investors With Losses To Contact The Firm Business Wire
10:30AM  Investor Alert: Glancy Prongay & Murray LLP Commences Investigation on Behalf of Zosano Pharma Corporation Investors Business Wire
Apr-07-16 11:09AM  Scott + Scott, LLP Announces Investigation of Zosano Pharma Corp (ZSAN), Encourages Investors with Losses to Contact Firm Business Wire
09:03AM  ZOSANO PHARMA CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Mar-30-16 02:00PM  Edited Transcript of ZSAN earnings conference call or presentation 29-Mar-16 8:30pm GMT
Mar-29-16 04:36PM  Zosano Pharma Reports Fourth Quarter and 2015 Financial Results and Business Update at noodls +5.33%
04:08PM  ZOSANO PHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Costs Associated with Exit or D
04:05PM  Zosano Pharma Reports Fourth Quarter and 2015 Financial Results and Business Update GlobeNewswire
07:07AM  Q4 2015 Zosano Pharma Corp Earnings Release - Time Not Supplied
Mar-21-16 08:49AM  Zosano Pharma to Report Fourth Quarter and 2015 Financial Results and to Provide a Corporate Update at noodls
Zosano Pharma Corporation, a clinical stage pharmaceutical company, develops a proprietary intracutaneous delivery system to administer drugs through the skin for rapid symptom relief to patients. Its lead product candidate is M207, a proprietary formulation of zolmitriptan used for the treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Erbez GeorgiaCFO and Chief Business OfficerMay 25Buy1.3268,00089,760115,750May 25 08:55 PM
WALKER JOHN PETERInterim CEOMay 25Buy1.3737,55051,338206,894May 25 08:45 PM
WALKER JOHN PETERInterim CEOMay 24Buy1.3436,16648,553169,344May 25 08:45 PM
Alataris KonstantinosPresident, CEOMar 20Option Exercise1.45127,389184,714254,778Mar 22 05:39 PM